Teclison
About:
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Website: http://teclison.com/
Top Investors: Nestor Capital, WTT Investment
Description:
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Total Funding Amount:
$5.9M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Montclair, New Jersey, United States
Founded Date:
2014-01-01
Contact Email:
info(AT)teclison.com
Founders:
Ray Lee
Number of Employees:
11-50
Last Funding Date:
2022-02-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai